TERUMO CORP - Dusseldorf Stock Exchang (TUO DU) stock market data APIs
€14.5328
-0.03(-0.2%)
as of September 15, 2025
Try our APIs with
free plan!
TERUMO CORP - Dusseldorf Stock Exchang Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for TUO.DU.
Prev. Close
14.5328
Open
14.5005
High
14.5005
Low
14.5328
52 wk Range
13.1-19.5076
Market Cap
27 604 M
EPS
-0.01
Dividends (Yield)
0.4605
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get TERUMO CORP - Dusseldorf Stock Exchang data using free add-ons & libraries
Get TERUMO CORP - Dusseldorf Stock Exchang Fundamental Data
TERUMO CORP - Dusseldorf Stock Exchang Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2018-06-30
- EPS/Forecast: NaN
Get TERUMO CORP - Dusseldorf Stock Exchang End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
TERUMO CORP - Dusseldorf Stock Exchang News
New
Opportunities in the Home Infusion Therapy Market 2025-2035 Featuring Strategic Analysis of Baxter International, B. Braun Melsungen, Fresenius Kabi, Medtronic, Terumo and More
Company Logo The market offers opportunities through increasing adoption due to rising chronic diseases, telehealth integration, and technological advancements. However, reimbursement challenges pers...
Assessing Terumo (TSE:4543) Valuation After Recent Share Price Swings
Terumo (TSE:4543) Stock Moves: Is This a Signal to Reevaluate? If you’ve been following Terumo (TSE:4543), the recent share price swings may have caught your attention and left you wondering what�...
Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva
Company Logo The Acute Respiratory Distress Syndrome (ARDS) market is projected to grow from $1.32 billion in 2024 to $2.53 billion by 2033, registering a CAGR of 7.51% from 2025 to 2033. Key factors...
Federal Reserve Outlook Galvanizes Asian Stock Markets
Asian stock markets rallied on Monday, following dovish commentary late Friday by US Federal Reserve PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
